NEWS

March 2, 2020

Karyopharm Announces Phase 3 BOSTON Study Meets Primary Endpoint with Significant Increase in Progression-Free Survival in Patients with Multiple Myeloma Following One to Three Prior Lines of Therapy

February 25, 2020

RedHill Biopharma Acquires Rights to Movantik^® from AstraZeneca

February 25, 2020

RedHill Biopharma Enters $115 Million Non-Dilutive Financing Agreement with HealthCare Royalty Partners

January 9, 2020

HealthCare Royalty Partners Raises $1.8 Billion

October 25, 2019

GSK receives prestigious Prix Galien USA award for SHINGRIX

September 16, 2019

Karyopharm Enters Into Royalty Agreement with Healthcare Royalty Partners for up to $150 Million

March 6, 2019

Infinity Pharmaceuticals Announces Royalty Monetization of COPIKTRA™ for $30 Million Gross Proceeds

March 1, 2019

Portola Pharmaceuticals Enters into $125 Million Loan Agreement with HealthCare Royalty Partners and Athyrium Capital Management

February 27, 2019

Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results

January 7, 2019

Coherus BioSciences Secures $75 Million Credit Financing with HealthCare Royalty Partners